Johnson & Johnson Declares Q1 2026 Dividend, Signals Stability
NEW BRUNSWICK, NEW JERSEY | January 2, 2026 — Johnson & Johnson announced that its Board of Directors has...
corporate governance
Advertisement
BYT Launches NCIB Amid AGM Results to Strengthen Corporate Outlook
Vancouver, British Columbia — December 2, 2025 — BYT Holdings Ltd. announced its plan to initiate a Normal Course...
Protagenic Therapeutics Faces Nasdaq Delisting After Dual Compliance Failures
NEW YORK, NY — November 27, 2025: Protagenic Therapeutics, Inc., a clinical-stage biopharmaceutical company, has announced receipt of a...
Medexus Announces 10% NCIB to Strengthen Shareholder Value
Toronto, Ontario & Chicago, Illinois — November 20, 2025 — Medexus Pharmaceuticals Inc. has announced that the Toronto Stock...
CS Diagnostics Strengthens Financial Structure Through Share Conversion
NEW YORK, November 3, 2025 — CS Interpharm and CS Diagnostics Pharma (CSDX) have announced the completion of a...
Advertisements
Phio Pharmaceuticals Strengthens Governance with New Lead Director
King of Prussia, Pennsylvania – October 31, 2025 — Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biopharmaceutical company developing...
PharmaDrug Restructures Debt to Strengthen Biopharma Pipeline
Toronto, Ontario – October 31, 2025 — PharmaDrug Inc. (CSE: PHRX; OTC Pink: LMLLF), a specialty pharmaceutical company focused...
Advertisement
